EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Modifiable factors associated with Huntington's disease progression in presymptomatic participants

Andres Gil-Salcedo iD, Renaud Massart, Laurent Cleret de Langavant iD, Anne-Catherine Bachoud-Levi

Annals of Clinical and Translational Neurology · 2024

DOI: 10.1002/acn3.52120 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Annals of Clinical and Translational Neurology, 2024. Verfasst von Andres Gil-Salcedo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Département d'Études Cognitives, École Normale Supérieure, PSL University, Paris, 75005, France. Hauptthemen laut MEDLINE: Huntington Disease, Disease Progression, Prodromal Symptoms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation pour la Recherche Médicale, Infrastructure NeurATRIS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Huntington's disease (HD) is a neurodegenerative disorder characterized by progressive motor, cognitive, and psychiatric symptoms. Our aim here was to identify factors that can be modified to slow disease progression even before the first symptoms appear.

Methods

We included 2636 presymptomatic individuals (comparison with family controls) drawn from the prospective observational cohort Enroll‐HD, with more than 35 CAG repeats and at least two assessments of disease progression measured with the composite Huntington's disease rating Scale (cUHDRS). The association between sociodemographic factors, health behaviors, health history, and cUHDRS trajectory was assessed with a mixed‐effects random forest using partial dependence plots and Shapley additive explanation method.

Results

Participants were followed by an average of 3.4 (SD = 1.97) years. We confirmed the negative impact of age and a high number of CAG repeats. We found that a high level of education, a body mass index (BMI) 23 kg/m 2 thereafter, alcohol consumption of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseDisease ProgressionProdromal SymptomsHumansFemaleMaleAdultMiddle AgedProspective StudiesBody Mass IndexAsymptomatic Diseases

Autor:innen und Institutionen

  • Département d'Études Cognitives, École Normale Supérieure, PSL University, Paris, 75005, France.
  • Faculté de Médecine, Université Paris-Est Créteil, Créteil, 94000, France.
  • Inserm U955, Institut Mondor de Recherche Biomédicale, Équipe NeuroPsychologie Interventionnelle, Créteil, 94000, France.
  • NeurATRIS, Mondor Node, Créteil, France.
  • APHP, Hôpital Henri Mondor, service de neurologie, centre national de référence maladie de Huntington, Créteil, 94000, France.

ORCID-Profile: Andres Gil-Salcedo, Laurent Cleret de Langavant

Förderung

  • Fondation pour la Recherche Médicale
  • Infrastructure NeurATRIS

Zitieren

APA

Gil-Salcedo, A., Massart, R., de Langavant, L. C., & Bachoud-Levi, A. C. (2024). Modifiable factors associated with Huntington's disease progression in presymptomatic participants. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52120

Vancouver

Gil-Salcedo A, Massart R, de Langavant LC, Bachoud-Levi AC. Modifiable factors associated with Huntington's disease progression in presymptomatic participants. Annals of Clinical and Translational Neurology. 2024. doi:10.1002/acn3.52120

BibTeX
@article{GilSalcedo2024,
  author = {Gil-Salcedo, Andres and Massart, Renaud and de Langavant, Laurent Cleret and Bachoud-Levi, Anne-Catherine},
  title = {Modifiable factors associated with Huntington's disease progression in presymptomatic participants},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2024},
  doi = {10.1002/acn3.52120}
}
Kostenlos starten →